Breast

Breast cancer occurs in one in eight women throughout life. It is the most common cancer in women, accounting for 29% of all cancers affecting women.

After having removed the tumor at is first appearance, in some cases the disease may progress to further skin spread, metastases, both near the site of tumor removal, and in a skin area not near the surgically treated breast.

In these cases, combining with a systemic therapy an effective local control of the cutaneous disease the survival rate increases to 15 years by 4.9%.

Electrochemotherapy is indicated for the local control of the cutaneous spread of the disease regardless of the type of primary tumour (positive hormone, HER2 positive or triple negative), with a success rate of over 70%.

We would advise you to consult your doctor to find out if electrochemotherapy can help you.

The technology that can be used to treat skin metastases from breast cancer is Cliniporator®.

Please write to oncology@igeamedical.com to find out which hospital is closest to you.

The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2019